Abbott Laboratories (ABT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbott Laboratories.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.636 fourth quarter 2025 earnings conference call. 00:00:03.636 -- 00:00:07.241 All participants will be able to listen only until the question and answer portion of 00:00:07.241 -- 00:00:12.187 this call. During the question and answer session, you will be able to ask your question 00:00:12.187 -- 00:00:15.812 by pressing the star one one keys on your touchtone phone. 00:00:15.812 -- 00:00:20.879 This call is being recorded by Abbott. With the exception of any participants questions 00:00:20.879 -- 00:00:25.746 asked during the question and answer session, the entire call, including the question 00:00:25.746 -- 00:00:29.377 and answer session, is material copyrighted by Abbott. 00:00:29.377 -- 00:00:34.542 It cannot be recorded or rebroadcast without Abbott Express written permission. 00:00:34.542 -- 00:00:40.467 I would now like to introduce Mr. Mike Camilla, Vice President, Investor Relations. 00:00:41.049 -- 00:00:43.372 Good morning, and thank you for joining us. 00:00:43.372 -- 00:00:48.697 With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreau, 00:00:48.697 -- 00:00:53.142 Executive Vice President, Finance and Chief Financial Officer. 00:00:53.142 -- 00:00:55.725 Robert and Phil will provide opening remarks. 00:00:55.725 -- 00:00:58.992 Following their comments, we'll take your questions. 00:00:58.992 -- 00:01:03.439 Before we get started, some statements made today may be forward-looking for purposes 00:01:03.439 -- 00:01:08.286 of the Private Securities Litigation Reform Act of 1995, including 00:01:08.286 -- 00:01:11.909 the expected results for 2026. 00:01:13.174 -- 00:01:18.021 Abbott cautions that these forward-looking statements are subject to risks and uncertainties 00:01:18.021 -- 00:01:22...